Danaher Corporation (DHR) Stake Decreased by Sii Investments Inc. WI
Sii Investments Inc. WI decreased its stake in Danaher Corporation (NYSE:DHR) by 1.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,283 shares of the conglomerate’s stock after selling 80 shares during the period. Sii Investments Inc. WI’s holdings in Danaher Corporation were worth $454,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Peddock Capital Advisors LLC raised its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter valued at about $157,000. Motco raised its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC raised its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares during the last quarter. Finally, Cedar Wealth Management LLC raised its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares during the last quarter. 76.56% of the stock is currently owned by institutional investors and hedge funds.
Danaher Corporation (NYSE DHR) traded up 0.88% on Friday, reaching $79.99. 929,341 shares of the company’s stock were exchanged. The company has a market cap of $55.57 billion, a P/E ratio of 25.53 and a beta of 1.03. The firm has a 50 day moving average of $83.07 and a 200-day moving average of $84.21. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter in the prior year, the firm earned $0.90 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. Equities analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Danaher Corporation (DHR) Stake Decreased by Sii Investments Inc. WI” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/danaher-corporation-dhr-stake-decreased-by-sii-investments-inc-wi/1475593.html.
Several equities research analysts have recently issued reports on the stock. Jefferies Group LLC reissued a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Wells Fargo & Company assumed coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $92.00 price target on shares of Danaher Corporation in a research note on Sunday, April 23rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $91.76.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the company’s stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock worth $3,206,426 in the last ninety days. Insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.